Ikena Oncology, Inc.
General ticker "IKNA" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $75.3M (TTM average)
Ikena Oncology, Inc. follows the US Stock Market performance with the rate: 16.3%.
Estimated limits based on current volatility of 1.3%: low 1.32$, high 1.35$
Factors to consider:
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.04$, 2.86$]
- 2025-12-31 to 2026-12-31 estimated range: [1.24$, 3.17$]
Financial Metrics affecting the IKNA estimates:
- Negative: Non-GAAP EPS, $ of -0.92 <= 0.05
- Negative: Operating cash flow per share per price, % of -36.59 <= 1.99
- Negative: negative Net income
- Negative: Operating profit margin, % of -100 <= 0.04
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
- Positive: Shareholder equity ratio, % of 88.99 > 63.58
- Negative: Industry operating cash flow per share per price (median), % of -20.97 <= 2.94
Short-term IKNA quotes
Long-term IKNA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.62MM | $9.16MM | $0.00MM |
| Operating Expenses | $86.52MM | $84.58MM | $58.97MM |
| Operating Income | $-70.90MM | $-75.42MM | $-58.97MM |
| Non-Operating Income | $2.14MM | $7.09MM | $9.89MM |
| R&D Expense | $64.32MM | $59.65MM | $30.88MM |
| Income(Loss) | $-68.77MM | $-68.33MM | $-49.08MM |
| Taxes | $0.00MM | $-0.16MM | $0.15MM |
| Profit(Loss)* | $-66.63MM | $-68.17MM | $-49.23MM |
| Stockholders Equity | $146.97MM | $169.76MM | $125.93MM |
| Assets | $172.26MM | $192.09MM | $141.51MM |
| Operating Cash Flow | $-74.11MM | $-79.74MM | $-46.00MM |
| Capital expenditure | $1.43MM | $0.41MM | $0.00MM |
| Investing Cash Flow | $-99.28MM | $64.14MM | $-34.90MM |
| Financing Cash Flow | $1.09MM | $75.98MM | $0.00MM |
| Earnings Per Share** | $-1.84 | $-1.63 | $-1.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.